ELAINA FEARER: Open Payments
NPI 1467154997 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 20 payments from 10 companies in 2025. Trend: 2023 $915 · 2024 $713 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Lilly USA, LLC | 5 | $96 |
| Novo Nordisk Inc | 4 | $76 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| PFIZER INC. | 2 | $47 |
| ABBVIE INC. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: BREZTRI, MOUNJARO, TRELEGY ELLIPTA, QULIPTA, PREVNAR 20, LEQVIO, JARDIANCE, ELIQUIS.
Industry payments across PA — which companies pay providers there.
